ISO Insider Trading

Insider Ownership Percentage: 6.40%
Insider Buying (Last 12 Months): $128,406.34
Insider Selling (Last 12 Months): $0.00

IsoPlexis Insider Trading History Chart

This chart shows the insider buying and selling history at IsoPlexis by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

IsoPlexis Share Price & Price History

Current Price: $1.75
Price Change: +0.30 (1.20%)
As of 09/23/2022 09:56 PM ET

This chart shows the closing price history over time for ISO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

IsoPlexis Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/30/2022Nachum ShamirDirectorBuy10,253$1.89$19,378.1710,253View SEC Filing Icon  
8/30/2022Nachum ShamirDirectorBuy10,253$1.89$19,378.1710,253View SEC Filing Icon  
8/25/2022John StrahleyCFOBuy10,000$2.00$20,000.0065,000View SEC Filing Icon  
8/25/2022Richard W Rew IISVPBuy20,000$1.99$39,800.0020,000View SEC Filing Icon  
8/25/2022Sean MackayCEOBuy15,000$1.99$29,850.00914,366View SEC Filing Icon  
See Full Table
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE.

He lives financially free trading this One Stock Once per month...
Ticker Revealed.

SEC Filings (Institutional Ownership Changes) for IsoPlexis (NASDAQ:ISO)

48.70% of IsoPlexis stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ISO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

IsoPlexis Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2022State Street Corp21,100$46K0.0%-82.8%0.054%Search for SEC Filing on Google Icon
8/15/2022Millennium Management LLC645,635$1.40M0.0%+30.6%1.652%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp14,321$31K0.0%-79.2%0.037%Search for SEC Filing on Google Icon
8/12/2022Corient Capital Partners LLC11,786$25K0.0%N/A0.030%Search for SEC Filing on Google Icon
5/16/2022State Street Corp122,811$0.42M0.0%+95.4%0.315%Search for SEC Filing on Google Icon
5/16/2022Ally Bridge Group NY LLC1,650,118$5.66M4.2%-6.8%4.226%Search for SEC Filing on Google Icon
5/13/2022Renaissance Technologies LLC10,444$36K0.0%N/A0.027%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.335,282$1.15M0.0%+10.6%0.859%Search for SEC Filing on Google Icon
5/12/2022Quadrant Private Wealth Management LLC31,053$0.11M0.0%+180.9%0.080%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp29,935$0.10M0.0%N/A0.077%Search for SEC Filing on Google Icon
5/10/2022South Dakota Investment Council84,094$0.29M0.0%N/A0.215%Search for SEC Filing on Google Icon
2/15/2022Northpond Ventures LLC8,805,272$80.92M28.3%N/A22.604%Search for SEC Filing on Google Icon
2/15/2022Davidson Kempner Capital Management LP31,500$0.29M0.0%N/A0.081%Search for SEC Filing on Google Icon
2/14/2022Parian Global Management LP122,330$1.12M0.9%N/A0.314%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC4,095,498$37.64M0.6%N/A10.513%Search for SEC Filing on Google Icon
2/14/2022Ghisallo Capital Management LLC20,000$0.18M0.0%N/A0.051%Search for SEC Filing on Google Icon
2/14/2022Sio Capital Management LLC495,012$4.55M1.4%N/A1.271%Search for SEC Filing on Google Icon
2/14/2022Ally Bridge Group NY LLC1,770,118$16.27M5.7%N/A4.544%Search for SEC Filing on Google Icon
2/8/2022Quadrant Private Wealth Management LLC11,053$0.10M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp70,080$0.64M0.0%N/A0.180%Search for SEC Filing on Google Icon
2/2/2022New York State Common Retirement Fund9,751$90K0.0%N/A0.025%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
IsoPlexis logo
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.
Read More on IsoPlexis

Today's Range

Now: $1.75
Low: $1.65
High: $1.79

50 Day Range

MA: $2.42
Low: $1.75
High: $3.74

52 Week Range

Now: $1.75
Low: $1.62
High: $16.95

Volume

26,200 shs

Average Volume

86,538 shs

Market Capitalization

$68.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of IsoPlexis?

IsoPlexis' top insider shareholders include:
  1. Sean Mackay (CEO)
  2. John Strahley (CFO)
  3. Richard W Rew II (SVP)
  4. Nachum Shamir (Director)
Learn More about top insider investors at IsoPlexis.

Who are the major institutional investors of IsoPlexis?

IsoPlexis' top institutional investors include:
  1. Millennium Management LLC — 1.65%
  2. State Street Corp — 0.05%
  3. Northern Trust Corp — 0.04%
  4. Corient Capital Partners LLC — 0.03%
Learn More about top institutional investors of IsoPlexis stock.

Which institutional investors are selling IsoPlexis stock?

Within the previous quarter, ISO stock was sold by these institutional investors:
  1. State Street Corp
  2. Northern Trust Corp

Which institutional investors are buying IsoPlexis stock?

During the previous quarter, ISO stock was acquired by institutional investors including:
  1. Millennium Management LLC
  2. Corient Capital Partners LLC
In the last year, these company insiders have bought IsoPlexis stock:
  1. Sean Mackay (CEO)
  2. John Strahley (CFO)
  3. Richard W Rew II (SVP)
  4. Nachum Shamir (Director)
Learn More investors buying IsoPlexis stock.